Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.426NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.581NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.330NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.177NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.301NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.308NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.325NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.590NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.496NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.438.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
AY.49 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.497NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.30 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.85 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.571NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.55 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.239NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.574NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
GA.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used